Rebbeck CA, Thomas R, Breen M, Leroi AM, Burt A. 2009. Origins and Evolution of a Transmissible Cancer. Evolution. 63 (9): 2340–2349. doi:10.1111/j.1558-5646.2009.00724.x. PMID19453727CS1 održavanje: više imena: authors list (link)
Mukaratirwa S, Gruys E. 2003. Canine transmissible venereal tumour: cytogenetic origin, immunophenotype, and immunobiology. A review. The Veterinary quarterly. 25 (3): 101–11. doi:10.1080/01652176.2003.9695151. PMID14535580
Stettner N, Brenner O, Eilam R, Harmelin A. 2005. Pegylated liposomal doxorubicin as a chemotherapeutic agent for treatment of canine transmissible venereal tumor in murine models. J. Vet. Med. Sci. 67 (11): 1133–9. doi:10.1292/jvms.67.1133. PMID16327225CS1 održavanje: više imena: authors list (link)
Liao K, Hung S, Hsiao Y, Bennett M, Chu R. 2003. Canine transmissible venereal tumor cell depletion of B lymphocytes: molecule(s) specifically toxic for B cells. Vet. Immunol. Immunopathol. 92 (3–4): 149–62. doi:10.1016/S0165-2427(03)00032-1. PMID12730015CS1 održavanje: više imena: authors list (link)
Papazoglou L, Koutinas A, Plevraki A, Tontis D. 2001. Primary intranasal transmissible venereal tumour in the dog: a retrospective study of six spontaneous cases. Journal of veterinary medicine. A, Physiology, pathology, clinical medicine. 48 (7): 391–400. doi:10.1046/j.1439-0442.2001.00361.x. PMID11599677CS1 održavanje: više imena: authors list (link)
Rebbeck CA, Thomas R, Breen M, Leroi AM, Burt A. 2009. Origins and Evolution of a Transmissible Cancer. Evolution. 63 (9): 2340–2349. doi:10.1111/j.1558-5646.2009.00724.x. PMID19453727CS1 održavanje: više imena: authors list (link)
Hasler A, Weber W. 2000. Theriogenology question of the month. Transmissible venereal tumor (TVT). J. Am. Vet. Med. Assoc. 216 (10): 1557–9. PMID10825939
Mukaratirwa S, Gruys E. 2003. Canine transmissible venereal tumour: cytogenetic origin, immunophenotype, and immunobiology. A review. The Veterinary quarterly. 25 (3): 101–11. doi:10.1080/01652176.2003.9695151. PMID14535580
Stettner N, Brenner O, Eilam R, Harmelin A. 2005. Pegylated liposomal doxorubicin as a chemotherapeutic agent for treatment of canine transmissible venereal tumor in murine models. J. Vet. Med. Sci. 67 (11): 1133–9. doi:10.1292/jvms.67.1133. PMID16327225CS1 održavanje: više imena: authors list (link)
Liao K, Hung S, Hsiao Y, Bennett M, Chu R. 2003. Canine transmissible venereal tumor cell depletion of B lymphocytes: molecule(s) specifically toxic for B cells. Vet. Immunol. Immunopathol. 92 (3–4): 149–62. doi:10.1016/S0165-2427(03)00032-1. PMID12730015CS1 održavanje: više imena: authors list (link)
Rogers K, Walker M, Dillon H. 1998. Transmissible venereal tumor: a retrospective study of 29 cases. Journal of the American Animal Hospital Association. 34 (6): 463–70. PMID9826280CS1 održavanje: više imena: authors list (link)
Papazoglou L, Koutinas A, Plevraki A, Tontis D. 2001. Primary intranasal transmissible venereal tumour in the dog: a retrospective study of six spontaneous cases. Journal of veterinary medicine. A, Physiology, pathology, clinical medicine. 48 (7): 391–400. doi:10.1046/j.1439-0442.2001.00361.x. PMID11599677CS1 održavanje: više imena: authors list (link)